Nisa Investment Advisors
KYMR icon

Nisa Investment Advisors’s Kymera Therapeutics KYMR Stock Holding History

Nisa Investment Advisors’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$163K Buy
1,421
+421
+42% +$36.2K ﹤0.01% 1328
2026
Q1 		$83.3K Buy
1,000
+501
+100% +$39.7K ﹤0.01% 1494
2025
Q4 		$38.8K Hold
499
– – ﹤0.01% 1703
2025
Q3 		$28.2K Sell
499
-5
-1% -$226 ﹤0.01% 1835
2025
Q2 		$22K Sell
504
-51
-9% -$1.76K ﹤0.01% 1890
2025
Q1 		$15.2K Sell
555
-30
-5% -$1.09K ﹤0.01% 1992
2024
Q4 		$23.5K Buy
585
+51
+10% +$2.3K ﹤0.01% 1887
2024
Q3 		$25.3K Buy
534
+60
+13% +$2.65K ﹤0.01% 1831
2024
Q2 		$14.1K Buy
474
+23
+5% +$796 ﹤0.01% 2055
2024
Q1 		$18.1K Buy
451
+61
+16% +$2.18K ﹤0.01% 1928
2023
Q4 		$9.93K Sell
390
-1,315
-77% -$23.5K ﹤0.01% 2043
2023
Q3 		$23.7K Buy
1,705
+6
+0.4% +$121 ﹤0.01% 1965
2023
Q2 		$39.1K Hold
1,699
– – ﹤0.01% 1833
2023
Q1 		$50K Sell
1,699
-370
-18% -$11.9K ﹤0.01% 1717
2022
Q4 		$52K Hold
2,069
– – ﹤0.01% 1755
2022
Q3 		$63K Sell
2,069
-68
-3% -$1.79K ﹤0.01% 1657
2022
Q2 		$42K Buy
2,137
+1,650
+339% +$38.5K ﹤0.01% 1791
2022
Q1 		$21K Sell
487
-740
-60% -$31.3K ﹤0.01% 2039
2021
Q4 		$52K Buy
1,227
+447
+57% +$26K ﹤0.01% 1720
2021
Q3 		$46 Sell
780
-1,318
-63% -$76.4K ﹤0.01% 1954
2021
Q2 		$102 Hold
2,098
– – ﹤0.01% 1683
2021
Q1 		$82 Hold
2,098
– – ﹤0.01% 1833
2020
Q4 		$130K Buy
+2,098
New +$102K ﹤0.01% 1634

Other funds holding KYMR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $526M AUM 175.27% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Nisa Investment Advisors's KYMR Position: Q2 2026 in Review

Nisa Investment Advisors increased its Kymera Therapeutics (KYMR) stake by 42% in Q2 2026, buying an estimated $36.2K and bringing the position to 1,421 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #1328.

Nisa Investment Advisors first reported a position in KYMR in Q4 2020 and has held it in 23 quarters since. 96 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Nisa Investment Advisors held 1,421 shares of Kymera Therapeutics worth $163K as of Q2 2026.
  • Nisa Investment Advisors bought 421 Kymera Therapeutics shares in Q2 2026, an estimated $36.2K.
  • Kymera Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1328 holding.
  • Nisa Investment Advisors first reported a position in Kymera Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • 96 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.